Return to homepagePandemic Pact

VIVIT Vorarlberg Institute for Vascular Investigation and Treatment

  • Funded by Austrian Research Promotion Agency (FFG)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Austrian Research Promotion Agency (FFG)

  • Principal Investigator

    N/A

  • Research Location

    Austria

  • Lead Research Institution

    VIVIT Vorarlberg Institute for Vascular Investigation and Treatment

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

In the project applied for, an enzyme linked immunosorbent assay (ELISA) test platform is to be developed that detects antibodies that infected people have formed as a reaction of the immune system due to contact with the coronavirus SARS-CoV-2. This test should be more sophisticated and reliable than the antibody tests currently available on the market with their known problems (lack of specificity and sensitivity). The antibody detection is to be applied first to around 5000 people who work in the medical and nursing professions in Vorarlberg.